Literature DB >> 12970019

Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence.

David G Morris1, Robert M Jasmer, Laurence Huang, Michael B Gotway, Stephen Nishimura, Talmadge E King.   

Abstract

BACKGROUND: The chronic granulomatous inflammation of sarcoidosis has been hypothesized to depend on the CD4+ T-helper lymphocyte. HIV infection, which depletes these cells, has been reported to attenuate the manifestations of sarcoidosis. STUDY
OBJECTIVES: We asked whether the development of symptomatic sarcoidosis in the context of preexisting HIV infection was dependent on the CD4+ lymphocyte count.
DESIGN: We performed a retrospective standardized chart review of all patients who developed granulomatous inflammation following HIV infection at an urban academic referral center. MEASUREMENTS: We identified seven patients with sarcoidosis within this cohort and compared their CD4+ lymphocyte count to that in a cohort of 16 patients in whom similar granulomatous inflammation was found but who did not have sarcoidosis. We then compared our cases to all reported cases using a systematic literature review.
RESULTS: The CD4+ lymphocyte count was > 200 cells/ microL in all of our patients with HIV infection when they developed subsequent sarcoidosis. In contrast, specific etiologies for granulomatous inflammation were found in all 10 HIV-infected patients who presented with granulomatous inflammation and a CD4+ lymphocyte count of < 200 cells/ microL, with infectious etiologies found in 8 patients. Similarly, there was relative preservation of the CD4+ lymphocyte count in previously reported cases, with 14 of 19 patients (74%) having an absolute CD4+ lymphocyte count of > 200 cells/ microL.
CONCLUSIONS: We conclude that the development of the chronic granulomatous inflammation of sarcoidosis appears to depend on the preservation or restoration of the peripheral CD4+ lymphocyte count and that in most cases the CD4+ lymphocyte count exceeds 200 cells/ microL. Furthermore, alternative specific etiologies of granulomatous inflammation are generally identifiable in HIV-infected patients with peripheral CD4+ lymphocyte counts of < 200 cells/ microL.

Entities:  

Mesh:

Year:  2003        PMID: 12970019     DOI: 10.1378/chest.124.3.929

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Neurosarcoidosis.

Authors:  Dakshinamurty Gullapalli; Lawrence H Phillips
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

2.  Sarcoidosis and HTLV-1 infection.

Authors:  D H McKee; A C Young; M Haeney
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

3.  Incidence and Presentation of Sarcoidosis With and Without HIV Infection.

Authors:  Jennifer S Hanberg; Kathleen M Akgün; Evelyn Hsieh; Liana Fraenkel; Amy C Justice
Journal:  Open Forum Infect Dis       Date:  2020-09-18       Impact factor: 3.835

Review 4.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

Review 5.  Impact of antiretroviral therapy on lung immunology and inflammation.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

6.  HIV-Related Lung Disorders.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Drug Discov Today Dis Mech       Date:  2007

7.  SAPHO osteomyelitis and sarcoid dermatitis in a patient with DiGeorge syndrome.

Authors:  Harumi Jyonouchi; Kenneth W Lien; Helen Aguila; Gaetano G Spinnato; Sanjeev Sabharwal; Beth A Pletcher
Journal:  Eur J Pediatr       Date:  2006-02-21       Impact factor: 3.183

Review 8.  Role of CD4+ T cells in sarcoidosis.

Authors:  Johan Grunewald; Anders Eklund
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

Review 9.  Etiology of sarcoidosis: does infection play a role?

Authors:  Shiv Saidha; Elias S Sotirchos; Christopher Eckstein
Journal:  Yale J Biol Med       Date:  2012-03-29

10.  Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

Authors:  M Patricia George; Mouhamed Kannass; Laurence Huang; Frank C Sciurba; Alison Morris
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.